Disseminated strongyloidiasis in an immunocompromised male

Abstract

Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, DC. 33. Cammarata, S.K. et al. 2000. Linezolid versus cephalosporin therapy in the treatment of patients with communityacquired pneumonia: summary of two randomized trials. Eur. Respir. J. 16(Suppl. 3): 139S. 34. Cammarata, S.K. et al. 2000. Linezolid is superior to cephalosporins in treatment of patients with bacteremic Streptococcus pneumoniae communityacquired pneumonia.. Am. J. Respir. Crit. Care Med. 161(Suppl. 2): A654. 35. Stevens, D.L. et al. 2000. Randomized comparison of linezolid (PNU-100766) versus oxacillin-dicloxacillin for treatment of complicated skin and soft tissue infections. Antimicrob. Agents Chemother. 44:3408-3413. 36. Mangano, R. et al. 2000. Comparison of linezolid and flucoloxacillin in the treatment of complicated skin infections: analysis of European and South African patients in a regional phase III trial. Third International Meeting on the Therapy of Infections, Florence, Italy. 37. Melzer, M., D. Goldsmith, and W. Gransden. 2000. Successful treatment of vertebral osteomyelitis with linezolid in a patient receiving hemodialysis with persistent methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus bacteremias. Clin. Infect. Dis. 31:208-209. 38. Stalker, D.J., C.P. Wajszczuk, and D.H. Batts. 1997. Linezolid safety, tolerance, and pharmacokinetics following oral dosing twice daily for 14.5 days, abstr. A115. In Program and Abstracts of the 40th Interscienee Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, DC. 39. NCCLS. 2002. Performance standards for antimicrobial susceptibility testing-12th informational supplement. M 100S12. NCCLS. Wayne, PA. 40. Bouza, E. and E Mufioz. 2001. Linezolid: pharmacokinetic characteristics and clinical studies. Clin. Microbiol. Infect. 7(Suppl. 4):75-82. 41. Pharmacia and UpJohn Company. 2000. Linezolid prescribing information. Pharmacia and Up John Company, Kalamazoo, MI. 42. Cammarata, S.K. et al. 2000. Incidence of Clostridium difficile-related complications during clinical trials of linezolid, an oxazolidinone, abstr. 947. In Program and Abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, DC. 43. Zurenko, G.E. 2000. Oxazolidinones. Linezolid and beyond, abstr. 637. In Program and Abstracts of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, DC.